首页> 外文期刊>Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists >Percutaneous laser-facilitated thrombectomy: an innovative, easily applied, and effective therapeutic option for recanalization of acute and subacute thrombotic hemodialysis shunt occlusions.
【24h】

Percutaneous laser-facilitated thrombectomy: an innovative, easily applied, and effective therapeutic option for recanalization of acute and subacute thrombotic hemodialysis shunt occlusions.

机译:经皮激光促进血栓切除术:一种新颖,易于应用且有效的治疗选择,可用于对急性和亚急性血栓性血液透析分流闭塞进行再通。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: To report our experience with excimer laser-facilitated recanalization of acute and subacute thrombotic occlusions of hemodialysis shunts. METHODS: Twenty-one patients (16 women; mean age 54+/-19 years, range 31-76) presented with acute and subacute thrombotic occlusions of their hemodialysis shunts (4 Cimino, 17 prosthetic; 18 forearm, 3 upper arm); mean occlusion time was 4.1+/-3 days (range 1-14), and the thrombotic occlusion measured a mean 17.4+/-9 cm (range 5-27). Fresh thrombus was observed in addition to the total shunt occlusion in all cases. All patients were treated initially with a pulsed ultraviolet (308-nm) excimer laser. Eighteen (85.7%) patients received adjunctive local thrombolysis for treatment of residual thrombus. Nineteen (90.5%) patients underwent angioplasty of the underlying anastomotic stenosis. RESULTS: The angiographic occlusion was reduced from 100% to 63%+/-28% after laser treatment and to 36%+/-18% after 1 hour of thrombolytic therapy (20 mg tissue plasminogen activator). TIMI flow increased significantly from grade 0 to 2.7+/-0.5 following laser ablation (p<0.001) and to 3.0+/-0.2 upon completion of the angioplasty procedure (p>0.001 versus baseline). The immediate procedural success was 95.2% (20/21). Detectable thrombotic embolization and laser-related complications were not observed in any case. Primary patency was 85%; 3 patients had abnormal Doppler flow within 6 weeks and underwent reintervention (secondary patency 100%). All successfully treated shunts were usable for further dialysis at the 6-week follow-up. CONCLUSION: Percutaneous excimer laser-facilitated thrombus vaporization is safe and effective for recanalization of acute and subacute thrombotic occlusions of hemodialysis shunts.
机译:目的:报告我们在用准分子激光促进血液透析分流的急性和亚急性血栓形成闭塞再通方面的经验。方法:21名患者(16名妇女;平均年龄54 +/- 19岁,范围31-76)表现出血液透析分流的急性和亚急性血栓闭塞(Cimino 4,假体17;前臂18,上臂3);平均阻塞时间为4.1 +/- 3天(范围1-14),血栓形成阻塞的平均时间为17.4 +/- 9 cm(范围5-27)。在所有情况下,除总分流闭塞外,还观察到新鲜血栓。最初,所有患者均使用脉冲紫外(308 nm)准分子激光治疗。十八名(85.7%)患者接受了辅助性局部溶栓治疗,以治疗残余血栓。十九名(90.5%)患者接受了基本吻合口狭窄的血管成形术。结果:激光治疗后,血管造影的阻塞率从100%降低到63%+ /-28%,溶栓治疗(20 mg组织纤溶酶原激活剂)治疗1小时后,血管造影的阻塞率降低到36%+ /-18%。激光消融后,TIMI流量从0级显着增加到2.7 +/- 0.5(p <0.001),在完成血管成形手术后增加到3.0 +/- 0.2(相对于基线,p> 0.001)。即时程序成功率为95.2%(20/21)。在任何情况下均未观察到可检测到的血栓栓塞和与激光相关的并发症。主要通畅率为85%; 3例患者在6周内出现多普勒血流异常,并接受了再次干预(二次通畅率100%)。在6周的随访中,所有成功治疗的分流器均可用于进一步透析。结论:经皮准分子激光促进的血栓汽化对于血液透析分流的急性和亚急性血栓栓塞的再通是安全有效的。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号